<html>
<head>PUBMED IDs for p33ING2</head>
<body bgcolor='#C5F0F2'><h1>p33ING2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11481424/'>DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.</a> August 2  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12545155/'>A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.</a> January 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15005689/'>Loss of heterozygosity on chromosome 4q32-35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genes.</a> March 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15748897/'>The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells.</a> March 8  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16488987/'>The novel tumor suppressor p33ING2 enhances nucleotide excision repair via inducement of histone H4 acetylation and chromatin relaxation.</a> February 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17929852/'>The tumor suppressors p33ING1 and p33ING2 interact with alien in vivo and enhance alien-mediated gene silencing.</a> October 13  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18513492/'>ING2 recruits histone methyltransferase activity with methylation site specificity distinct from histone H3 lysines 4 and 9.</a> June 3  2008<br></body></html>
